ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,137Medicare Part D Prescriptions Filled, Including Refills

Rank: 100 out of 663

$425K Total Retail Price of All Prescriptions

Rank: 109 out of 663

573 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Colorado
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 573 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

9% of this provider’s 573 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 6,651 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Colorado
LEVOTHYROXINE SODIUM 450 423 1 3
LISINOPRIL 273 253 2 2
SIMVASTATIN 245 207 3 1
METOPROLOL TARTRATE 242 210 4 11
AMLODIPINE BESYLATE 221 202 5 5
HYDROCODONE-ACETAMINOPHEN 218 163 S3 6 6
OMEPRAZOLE 212 169 7 4
ATORVASTATIN CALCIUM 185 183 8 13
FUROSEMIDE 176 172 9 7
HYDROCHLOROTHIAZIDE 162 119 10 12
WARFARIN SODIUM 155 136 11 8
METFORMIN HCL 139 119 12 9
METOPROLOL SUCCINATE 118 105 13 25
LOSARTAN POTASSIUM 114 107 14 14
ALENDRONATE SODIUM 108 108 15 15
TRAMADOL HCL 103 73 16 17
GABAPENTIN 98 68 17 20
POTASSIUM CHLORIDE 86 75 18 23
ATENOLOL 83 78 19 10
DONEPEZIL HCL 81 81 20 40
CITALOPRAM HBR 79 61 21 18
ALLOPURINOL 76 46 22 28
MIRTAZAPINE 72 46 23 52
SERTRALINE HCL 70 70 24 35
ZOLPIDEM TARTRATE 69 43 25 16
CYMBALTA 67 34 26 54
CYCLOBENZAPRINE HCL 61 21 R 27 71
FOSINOPRIL SODIUM 59 47 28 213
PAROXETINE HCL 59 58 28 68
AMLODIPINE BESYLATE-BENAZEPRIL 58 53 30 127
MELOXICAM 57 23 31 61
PANTOPRAZOLE SODIUM 56 29 32 45
NEXIUM 55 32 33 43
GLYBURIDE 55 54 R 33 83
FENTANYL 54 47 S2 35 75
LISINOPRIL-HYDROCHLOROTHIAZIDE 53 44 36 22
LOVASTATIN 53 38 36 30
AMOX TR-POTASSIUM CLAVULANATE 53 33 36 193
ADVAIR DISKUS 53 52 36 53
AMITRIPTYLINE HCL 52 36 R 40 95
DIOVAN 52 52 40 59
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 1, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.